Cargando…
Co-formability, solubility enhancement and stability of olanzapine co-amorphous systems produced with different co-formers
INTRODUCTION: Strategies to address the problem of poorly water-soluble drugs encompass the conversion of a crystalline drug into an amorphous form to promote its apparent solubility and dissolution. Co-amorphous systems (CAMs) incorporate low molecular mass molecules (co-formers), which are mixed w...
Autores principales: | Bastos, Ana C., Santos, Inês A., Pinto, João F., Fernandes, Ana I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480635/ http://dx.doi.org/10.1080/07853890.2021.1896099 |
Ejemplares similares
-
Characterisation and stability of co-amorphous systems containing olanzapine and sulphonic acids
por: Santos, Inês A., et al.
Publicado: (2021) -
Assessment of the stability of co-amorphous olanzapine in tablets
por: da Costa, Nuno F., et al.
Publicado: (2021) -
Amorphous and Co-Amorphous Olanzapine Stability in Formulations Intended for Wet Granulation and Pelletization
por: da Costa, Nuno F., et al.
Publicado: (2022) -
Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder Blends
por: da Costa, Nuno F., et al.
Publicado: (2022) -
In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of Pellets
por: da Costa, Nuno F., et al.
Publicado: (2022)